Natus Medical Performance

BABY -- USA Stock  

USD 32.33  0.22  0.68%

Macroaxis gives Natus Medical performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of 0.2072 which conveys that as returns on market increase, Natus Medical returns are expected to increase less than the market. However during bear market, the loss on holding Natus Medical will be expected to be smaller as well.. Even though it is essential to pay attention to Natus Medical Incorp price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Natus Medical exposes twenty-eight different technical indicators which can help you to evaluate its performance. Natus Medical Incorp has expected return of -0.4853%. Please be advised to verify Natus Medical Incorporated Value At Risk as well as the relationship between Skewness and Day Median Price to decide if Natus Medical Incorp past performance will be repeated at some point in the near future.
 Time Horizon     30 Days    Login   to change

Natus Medical Incorp Relative Risk vs. Return Landscape

If you would invest  3,635  in Natus Medical Incorporated on June 20, 2018 and sell it today you would lose (380.00)  from holding Natus Medical Incorporated or give up 10.45% of portfolio value over 30 days. Natus Medical Incorporated is currently does not generate positive expected returns and assumes 1.7857% risk (volatility on return distribution) over the 30 days horizon. In different words, 16% of equities are less volatile than Natus Medical Incorporated and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 30 days, Natus Medical Incorporated is expected to under-perform the market. In addition to that, the company is 2.99 times more volatile than its market benchmark. It trades about -0.27 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.1 per unit of volatility.

Natus Medical Market Risk Analysis

Sharpe Ratio = -0.2718
Good Returns
Average Returns
Small Returns
Negative ReturnsBABY

Natus Medical Relative Performance Indicators

Estimated Market Risk
  actual daily
 84 %
of total potential
Expected Return
  actual daily
 1 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average Natus Medical is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Natus Medical by adding it to a well-diversified portfolio.

Performance Rating

Natus Medical Incorporated Risk Adjusted Performance Analysis

Risk-Adjusted Performance

Over the last 30 days Natus Medical Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions.

Natus Medical Alerts

Equity Alerts and Improvement Suggestions
Natus Medical Incorp generates negative expected return over the last 30 days
The company reported previous year revenue of 504.92 M. Net Loss for the year was (23.79 M) with profit before overhead, payroll, taxes, and interest of 287.59 M.
Over 92.0% of the company shares are held by institutions such as insurance companies
Latest headline from Neonatal Thermoregulation Market Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027
Check also Trending Equities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.